Literature DB >> 7934105

The restricted surgical relevance of morphologic criteria to classify systemic-pulmonary collateral arteries in pulmonary atresia with ventricular septal defect.

M C DeRuiter1, A C Gittenberger-de Groot, A J Bogers, N J Elzenga.   

Abstract

Now that systemic-pulmonary collateral arteries are used for unifocalization in patients with pulmonary atresia and ventricular septal defect, the question arises whether morphologic criteria of these collateral arteries could help to provide better results. In an attempt to classify the morphologic features of systemic-pulmonary collateral arteries, we studied 31 heart-lung autopsy specimens with pulmonary atresia and ventricular septal defect. The course of the systemic-pulmonary collateral arteries (origin, branching pattern, and connections with systemic and central pulmonary arteries) was related to their histologic characteristics. The results show that systemic-pulmonary collateral arteries cannot be classified according to their course related to the trachea and the main branches of the bronchi. The histologic features of these collateral arteries vary along their course to the lungs. Nearly all systemic-pulmonary collateral arteries contain a muscular or a musculoelastic segment. One type of collateral artery (complex loop anastomoses) is completely muscular and resembles a bronchial artery. Nutritive branches (bronchial arteries) arise from all histologic types of systemic-pulmonary collateral artery segments. The size and number of intimal proliferations in muscular, elastic, and musculoelastic segments did not differ significantly. In 29 of 31 cases a ductus arteriosus did not coexist with large collateral arteries (two cases unknown). It is concluded that a classification of large systemic-pulmonary collateral arteries based on morphologic features results in a highly variable system, which does not facilitate decisions for the suitability of these arteries for unifocalization procedures. The variability of the systemic-pulmonary collateral arteries corresponds with the recent embryologic finding that during development, collateral artery formation is possible during extended periods.

Entities:  

Mesh:

Year:  1994        PMID: 7934105

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Anatomy of the retro-oesophageal major aortopulmonary collateral arteries in patients with pulmonary atresia with ventricular septal defect: results from preoperative CTA.

Authors:  Qianjun Jia; Jianzheng Cen; Jinglei Li; Jian Zhuang; Hui Liu; Qun Zhang; Xiaoqing Liu; Meiping Huang; Changhong Liang
Journal:  Eur Radiol       Date:  2018-01-05       Impact factor: 5.315

2.  Relation of genotype 22q11 deletion to phenotype of pulmonary vessels in tetralogy of Fallot and pulmonary atresia-ventricular septal defect.

Authors:  M Chessa; G Butera; P Bonhoeffer; L Iserin; J Kachaner; S Lyonnet; A Munnich; D Sidi; D Bonnet
Journal:  Heart       Date:  1998-02       Impact factor: 5.994

3.  Clinical investigation of systemic-pulmonary collateral arteries.

Authors:  Chang-Hsien Yu; Ming-Ren Chen
Journal:  Pediatr Cardiol       Date:  2007-09-18       Impact factor: 1.655

4.  Assessment of right ventricular fibrosis in different forms of pulmonary atresia with ventricular septal defect.

Authors:  Pieter C van de Woestijne; Lennart Klompe; Peter L de Jong; Theodorus Hf Peters; Arie P Kappetein; Hari S Sharma; Ad Jjc Bogers
Journal:  Exp Clin Cardiol       Date:  2004

5.  Development of major aorto-pulmonary collateral arteries in vegf120/120 isoform mouse embryos with tetralogy of fallot.

Authors:  L A J Rammeloo; M C DeRuiter; N M van den Akker; L J Wisse; A C Gittenberger-de Groot
Journal:  Pediatr Cardiol       Date:  2014-07-29       Impact factor: 1.655

6.  Staged correction of pulmonary atresia, ventricular septal defect, and collateral arteries.

Authors:  Pieter van de Woestijne; Mostafa Mokhles; Ingrid van Beynum; Peter de Jong; Jeroen Wilschut; Ad Bogers
Journal:  J Card Surg       Date:  2022-02-09       Impact factor: 1.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.